Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

Clinical trial NCT07113574 · COMPLETED

Trial details

NCT number: NCT07113574
Sponsor: Karl Landsteiner Insitute for Nephrology and Haemato-Oncology
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Peritoneal Dialysis Associated Peritonitis Peritoneal Dialysis (PD)Peritoneal Dialysis Peritoneal Dialysis, Continuous Ambulatory Meropenem Aztreonam Antibacterial Agents Intraperitoneal Antibiotics Kidney Failure, Chronic Anti-Bacterial Agents Drug Therapy

Start date: 2021-08-31
Primary completion: 2022-07-24
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.